Angiogenesis and vasculogenesis. Therapeutic approaches for stimulation of post-natal neovascularization;Angiogenese und vaskulogenese therapeutische strategien zur stimulation der postnatalen neovaskularisation

Herz

Volumn 25, Issue 6, 2000, Pages 611-622

  Kalka, Christoph ^a   Asahara, Takayuki ^a   Krone, Wilhelm ^b   Isner, Jeffrey M ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Angiogenesis; Endothelial progenitor cells; Gene transfer; Vasculogenesis; VEGF

Indexed keywords

ANGIOGENIC FACTOR; CYTOKINE; DNA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; COLLATERAL CIRCULATION; DIABETIC RETINOPATHY; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; GENE THERAPY; ISCHEMIC HEART DISEASE; LIMB ISCHEMIA; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; POSTNATAL DEVELOPMENT; REPRODUCTION; STEM CELL; TUMOR GROWTH; WOUND HEALING;

EID: 0033815116     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00001974     Document Type: Article

References (91)

1. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity
2. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization
3. Gene therapy of endothelial progenitor cell for vascular development in severe ischemic disease
4. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization
5. Isolation of putative progenitor endothelial cells for angiogenesis
6. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells
7. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
8. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal
9. Isolation of endothelial cells and their progenitor cells from human peripheral blood
10. Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells
11. Hypoxia-induced paracrine regulation of VEGF receptor expression
12. Vascular permeability factor/ vascular endothelial growth factor: A multifunctional angiogenic cytokine
13. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
14. A common precursor for hematopoietic and endothelial cells
15. Angioblast differentiation and morphogenesis of the vascular endothelium in the mouse embryo
16. Interleukin 6 induces the expression of vascular endothelial growth factor
17. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis
18. Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/-mice
19. Mechanisms of angiogenesis
20. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice
21. Tec, a novel tyrosine kinase gene located on mouse chromosome-4, is expressed in endothelial cells and their presumptive precursors
22. Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo
23. Purification and biological properties of vasculotropin. A new angiogenic cytokine
24. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
25. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
26. Molecular and biological properties of the vascular endothelial growth factor family of proteins
27. Expression of the CD34 gene in vascular endothelial cells
28. Angiogenesis in cancer, vascular, rheumatoid and other disease
29. Tumor angiogenesis: Therapeutic implications
30. Regulation of VEGF expression in cultured keratinocytes. Implications for normal and impaired would healing
31. Scatter factor induces blood vessel formation in vivo
32. Isolation and characterization of endothelial progenitor cells from mouse embryos
33. Leoithoblast und Angioblast der Wirbeltiere
34. Therapeutic angiogenesis: A new frontier for vascular therapy
35. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: Preliminary clinical results
36. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb
37. Isner JM,Rosenfield K, Redefining the treatment of peripheral artery disease: Role of percutaneous revascularization
38. Therapeutic angiogenesis
39. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
40. Generation of differentiated endothelial cells from mononuclear cells of human umbilical cord blood
41. VEGF mobilizes endothelial progenitor cells after human gene therapy for myocardial neovascularization
42. Age dependent response in mobilization of endothelial progenitor cells (EPC) to VEGF gene therapy in human subjects
43. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neo-vascularization
44. Vascular endothelial growth factor (165) gene transfer augments circulating endothelial progenitor cells in human subjects
45. Vascular permeability factor, an endothelial cell mitogen related to PDGF
46. The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies
47. Hematopoietic colony-forming cells from mice after wound trauma
48. Origins of circulating endothelial cells and endothelial outgrowth from blood
49. Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia
50. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor
51. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
52. Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages
53. A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain
54. Vascular endothelial growth factor B, a novel growth factor for endothelial cells
55. Relationship between vasculogenesis, angiogenesis and haemopoiesis during avian ontogeny
56. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors
57. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endotehlial cells
58. Mechanisms of angiogenesis
59. Vasculogenesis
60. Vasculogenesis and angiogenesis in embryonic stem cell-derived embryoid bodies
61. Age-dependent impairment of angiogenesis
62. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF
63. Angiogenesis gene therapy: Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease
64. Studies on the origin of blood vessels and of red blood corpuscles as seen in the living blastoderm of chicks during the second day of incubation
65. Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease
66. Therapeutic angiogenesis with basic fibroblast growth factor: Technique and early results
67. Regulation of cardiovascular development and physiology by hypoxia-inducible factor 1
68. 2-terminal amino acid sequence of guinea pig tumor- secreted vascular permeability factor
69. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
70. Vascular permeability factor (VPF, VEGF) in tumor biology
71. A requirement for flk1 in primitive and definitive hematopoiesis and vasculogenesis
72. Evidence for circulating bone marrow-derived endothelial cells
73. Naked DNA encoding an hypoxia-inducible factor 1α (HIF-1α)/VP16 hybrid transcription factor enhances angiogenesis in rabiit hindlimb ischemia: An alternate method for therapeutic angiogenesis utilizing a transcriptional regulatory system
74. Circulating activated endothelial cells in sickle cell anemia
75. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes
76. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease
77. Arterial gene transfer of acidic fibroblast growth factor for therapeutic angiogenesis in vivo critical role of secretion signal in use of naked DNA
78. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization
79. Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo
80. Catheter-based myocardial gene transfer utilizing nonfluoroscopic electromechanical left ventricular mapping
81. Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines
82. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: The case for paracrine amplification of angiogenesis
83. Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps
84. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia
85. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4
86. Angiogenesis in ischemic heart disease
87. Vascular endothelial growth factor-C (VEGF-C/-2) promotes angiogenesis in the setting of tissue ischemia
88. Molecular cloning of a novel vascular endothelial growth factor, VEGF-D
89. flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors
90. KDR receptor: A key marker defining hematopoietic stem cells